Concept Medical Begins Patient Enrollment for MAGICAL-SV IDE Trial Comparing MagicTouch Balloon to Drug-Eluting Stents

Concept Medical Begins Patient Enrollment for MAGICAL-SV IDE Trial Comparing MagicTouch Balloon to Drug-Eluting Stents

Concept Medical has initiated patient enrollment for th […] The post Concept Medical Begins Patient Enrollment for MAGICAL-SV IDE Trial Comparing MagicTouch Balloon to Drug-Eluting Stents first appeared on GeneOnline News. The post Concept Medical Begins Patient Enrollment for MAGICAL-SV IDE Trial Comparing MagicTouch Balloon to Drug-Eluting Stents appeared first on GeneOnline News.

Concept Medical announces first patient enrolment in MAGICAL-SV IDE trial - Express Pharma

Concept Medical has announced the enrolment of the first patient in its MAGICAL-SV trial, a US Investigational Device Exemption (IDE) study assessing the MagicTouch Sirolimus-Coated Balloon (SCB) for treating small coronary artery lesions. The trial marks the company’s expansion into the United States and Europe with its coronary clinical programme. The first patient was enrolled at Mount Sinai Hospital, New York, by Dr Samin Sharma, Director of…